UPMC Hillman Cancer Center Italy

UPMC Hillman Cancer Center Italy is a state-of-the-art oncology facility in Rome, established in 2016 as part of the UPMC (University of Pittsburgh Medical Center) international network. As an extension of one of the world's leading cancer research and treatment institutions, the center brings UPMC's evidence-based cancer treatment protocols and clinical trial access to patients in Italy and across Southern Europe. The center holds JCI accreditation and operates according to UPMC's rigorous quality and safety standards. With 50 beds and dedicated oncology infrastructure, the facility represents a focused, specialized approach to cancer care, ensuring every resource is directed toward optimal treatment outcomes for cancer patients. The radiation therapy department features advanced linear accelerator technology for intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and image-guided radiation therapy (IGRT). The surgical oncology program covers a wide range of cancer surgeries with minimally invasive and robotic-assisted techniques. The hematology department manages blood cancers including leukemia, lymphoma, and multiple myeloma with advanced chemotherapy and targeted therapy protocols. The immunotherapy program provides cutting-edge immune checkpoint inhibitors, CAR-T cell therapy referrals, and access to UPMC's clinical trials for novel cancer treatments. Multidisciplinary tumor boards ensure every patient receives a personalized treatment plan developed by a team of oncologists, surgeons, radiation therapists, and pathologists. International patients benefit from UPMC's global patient services network, seamless medical record sharing across UPMC facilities worldwide, multilingual clinical coordinators, and Rome's excellent international connectivity.